These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24271834)

  • 21. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of intravenous metronidazole in Asian surgical patients.
    Ti TY; Lee HS; Khoo YM
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2248-51. PubMed ID: 8891123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition and metabolism of metronidazole in patients with liver failure.
    Farrell G; Baird-Lambert J; Cvejic M; Buchanan N
    Hepatology; 1984; 4(4):722-6. PubMed ID: 6745863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition and removal of metronidazole in patients undergoing haemodialysis.
    Somogyi A; Kong C; Sabto J; Gurr FW; Spicer WJ; McLean AJ
    Eur J Clin Pharmacol; 1983; 25(5):683-7. PubMed ID: 6662167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
    Tang-Liu DD; Richman JB; Lin P; Selim S
    Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
    Stüben J; Port R; Bertram B; Bollow U; Hull WE; Schaper M; Pohl J; Wiessler M
    Cancer Chemother Pharmacol; 1996; 38(4):355-65. PubMed ID: 8674159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PHARMACOKINETICS OF A SINGLE DOSE OF METRONIDAZOLE AFTER RECTAL ADMINISTRATION IN CAPTIVE ASIAN ELEPHANTS (ELEPHAS MAXIMUS).
    Sander SJ; Siegal-Willott JL; Ziegler J; Lee E; Tell L; Murray S
    J Zoo Wildl Med; 2016 Mar; 47(1):1-5. PubMed ID: 27010257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of sodium bimetrondazole glycinate in mice and rats].
    Liu CX; Wei GL; Xiao SH
    Yao Xue Xue Bao; 2000 Oct; 35(10):770-3. PubMed ID: 11372445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronidazole elimination is preserved in the elderly.
    Loft S; Egsmose C; Sonne J; Poulsen HE; Døssing M; Andreasen PB
    Hum Exp Toxicol; 1990 May; 9(3):155-9. PubMed ID: 2375881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials.
    Chabot GG; Abigerges D; Catimel G; Culine S; de Forni M; Extra JM; Mahjoubi M; Hérait P; Armand JP; Bugat R
    Ann Oncol; 1995 Feb; 6(2):141-51. PubMed ID: 7786822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition and cardioselectivity of MDL 74,405, a vitamin E-like free radical scavenger, in rats and dogs after intravenous infusion.
    Kuo BS; Mathews BS; Stuhler JD; Carrel BK; Ho J; Rose JQ
    Drug Metab Dispos; 1995 Jul; 23(7):757-64. PubMed ID: 7587965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of malaria infection and endotoxin-induced fever on the metabolism of antipyrine and metronidazole in the rat.
    Kokwaro GO; Ismail S; Glazier AP; Ward SA; Edwards G
    Biochem Pharmacol; 1993 Mar; 45(6):1243-9. PubMed ID: 8466545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of vitamin E on the distribution and metabolism of nitrofurantoin in rats.
    Statham CN; Minchin RF; Sasame HA; Kim SH; Boyd MR
    Drug Metab Dispos; 1985; 13(5):532-4. PubMed ID: 2865098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats.
    Kim MM; Lee SH; Lee MG; Hwang SJ; Kim CK
    Biopharm Drug Dispos; 1995 May; 16(4):279-93. PubMed ID: 7548777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady-state pharmacokinetics of metronidazole in Crohn's disease.
    Eradiri O; Jamali F; Thomson AB
    Biopharm Drug Dispos; 1987; 8(3):249-59. PubMed ID: 3593902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.
    Ouellet DM; Pollack GM
    Drug Metab Dispos; 1995 Apr; 23(4):478-84. PubMed ID: 7600915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
    Bae SK; Lee SJ; Kwon JW; Kim WB; Lee MG
    J Pharm Pharmacol; 2004 May; 56(5):635-42. PubMed ID: 15142341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.